Fes, Morocco – The Moroccan Ministry of Health has announced a decrease in the prices of 29 new medicines, as part of ongoing efforts to improve access to essential medicines for citizens.
The ministerial decision listing these reductions was published in the Official Gazette on May 23, 2024, and included a list of affected medicines with their new prices.
Important medicines covered by the reductions
The list of medicines that have had their prices reduced includes important medicines for the treatment of common diseases such as:
- High blood pressure
- Cancer
- Diabetes
- Chronic inflammation
- Joint pain
- Fever
Examples of reductions
- Jadenu 360 mg: Its price was reduced from 7,465 dirhams to 4,766 dirhams, a decrease of 36%.
- Jadenu 180 mg: Its price was reduced from 3,932 dirhams to 3,292 dirhams, a decrease of 16%.
- Femara 2.5 mg: Its price was reduced from 1,021 dirhams to 743 dirhams, a decrease of 27%.
- Axair 125μg: Its price was reduced from 140.90 dirhams to 101.70 dirhams, a decrease of 28%.
- Costarval 80 mg/12.5 mg: Its price was reduced from 82.90 dirhams to 63.10 dirhams, a decrease of 24%.
Other medicines for high blood pressure
The reductions also included several other high blood pressure medicines, such as:
- Co-Vartex 160mg/25mg
- Co-Zenovan 160/25mg
- Exforge 10mg/160mg
Importance of this step
This step aims to:
- Facilitate access to essential medicines for citizens
- Reduce the cost of treatment
- Improve public health
Government commitment to providing affordable medicines
This step comes as part of the Moroccan government’s commitment to providing affordable medicines to citizens and improving access to healthcare.
The government is working on implementing a number of other initiatives to achieve this goal, such as:
- Supporting the manufacture of local medicines
- Expanding health insurance coverage
- Strengthening control over medicine prices
In conclusion
The reduction in the prices of 29 new medicines is an important step by the Moroccan Ministry of Health to improve access to essential medicines for citizens.
This step shows the government’s commitment to improving public health and providing affordable healthcare.